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Background: Candida tropicalis is an increasingly important human pathogen associated with high mortality rates;
however, little is known regarding the virulence properties of C. tropicalis, particularly the production of haemolytic
factor. Although Candida spp may acquire iron from human blood red cells (RBCs) by producing a haemolytic factor
that promotes cell lyses, at present there are no data regarding the effect of RBCs on the production of haemolytic
molecules. The present study was undertaken to evaluate the role of human red blood cells on the production
haemolytic factor by C. tropicalis; in addition, the transcription levels of a putative haemolysin-like protein gene
(HLPt) were also analysed.
Results: C. tropicalis isolates produced a haemolytic factor following growth in either the absence or presence of
RBCs; however, distinct levels of haemolysis were observed, with 60% of the isolates exhibiting a significant increase in
the production of haemolytic factor when grown in the presence of human RBCs. All isolates in which the putative
HLPt gene was up-regulated in presence of human RBCs, ranging from 1.044 to 6.965-fold, also exhibited higher
haemolytic activity following growth in the presence of RBCs compared to that observed in the absence of RBCs.
Conclusions: We propose that human RBCs may induce changes in the phenotypic expression of haemolytic
factor and in transcriptional levels of the putative C. tropicalis HLPt gene in an isolate-dependent fashion.
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Non-Candida albicans Candida (NCAC) species are be-
ing increasingly reported as causative agents of severe
systemic infections [1,2]. Among NCAC species, Can-
dida tropicalis is one of the most commonly isolated
species in tropical countries. For instance, according to
recent epidemiological surveys, C. tropicalis is one of the
main causal agents of candidemia in Latin America and
Asia [3-7].
C. tropicalis is taxonomically close to Candida albi-
cans, sharing several pathogenic traits [8]. The clinical
importance of C. tropicalis infections is associated with
high rates of morbidity and mortality that may exceed
those reported for other Candida species, including C.
albicans [9,10]. However, compared with C. albicans,* Correspondence: furlaneto@uel.br
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attributes of C. tropicalis.
Haemolytic activity is known to be a putative virulence
factor contributing to disseminated candidal pathogen-
esis, particularly facilitating hyphal invasion in dissemi-
nated candidiasis [11,12]. The haemolytic factor of C.
albicans is a mannoprotein, which has a cell-wall man-
nan sugar moiety structure [13]. The mannan fraction
binds to the erythrocyte membrane, causing its rupture
and allowing the release of haemoglobin which may be
used as an iron source by the yeast [13-15].
The haemolytic capability of C. tropicalis has also been
recognized as a putative trait related to its pathogenesis
[16-20]. We have previously reported that a haemolytic
factor produced by clinical isolates of C. tropicalis is re-
leased in the culture supernatant and that its production
occurs in a glucose-dependent manner [19]. More re-
cently, our group demonstrated that binding of the
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ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Furlaneto et al. Journal of Biomedical Science  (2015) 22:13 Page 2 of 8reduced the haemolytic activity of C. tropicalis to simi-
lar level as that observed for C. albicans, suggesting
that the haemolytic factor secreted by C. tropicalis may
be a mannoprotein and giving evidence for its involve-
ment in haemolysis [20].
Currently, there are still few data concerning the mo-
lecular basis of haemolytic factor production by Can-
dida species. Lachke et al. [21] have described a putative
haemolysin gene in Candida glabrata termed HLP (hae-
molysin-like protein). Further, Luo et al. [22] demon-
strated a positive correlation between the expression of
HLP and haemolytic activity in C. glabrata.
In this study, we demonstrated for the first time that
human red blood cells modulate the production of the
haemolytic factor in C. tropicalis; furthermore, our data
revealed a positive correlation between the mRNA ex-
pression of a putative haemolysin-like protein gene and
the haemolytic activity in C. tropicalis isolates, which
suggests a positive effect of RBCs on haemolysis.
Methods
Candida tropicalis isolates
Clinical isolates recovered from blood (136.06, 144.06,
189.06, 301.07), nail infections (151.06) and tracheal se-
cretions (197.06, 201.06, 254.07, 344.07, 335.07) [23]
were maintained as stock cultures from the Fungal Gen-
etics Laboratory, The University of Londrina-Brazil on
yeast extract-peptone–D-glucose (YPD) agar at −20°C in
glycerol.
Preparation of red blood cells (RBCs)
Human RBCs (A+ type) were centrifuged at 1080 g for
7 min. The supernatant and buffy coats were removed,
and the packed RBCs were resuspended in Ca2+- and
Mg2+ -free phosphate-buffered saline (PBS-) and washed
twice with the same PBS-buffer and centrifugation. The
RBCs were then added to liquid RPMI 1640 medium
without phenol red (Sigma Chemical Co., St. Louis, MO,
USA) at a final concentration of 108 cells/ml.
Growth conditions
Prior to cultivation in either the presence or absence of
human RBCs, C. tropicalis isolates were grown overnight
to stationary phase in RPMI at 37°C and 180 rpm. The
procedure was repeated, after which cells were harvested
by centrifugation (3000 g for 10 min) and washed with
sterile buffer (PBS-). The resultant suspensions were
then inoculated with 104 yeast/ml in RPMI medium and
in RPMI supplemented with human RBCs type A+ (108
cells/ml) followed by incubation at 37°C and 180 rpm
for 48 h. Finally, cells were harvested by centrifugation
(3000 g for 5 min) and used for RNA extraction. The
resulting culture supernatants were assayed for haemo-
lytic activity.Haemolytic activity in the cell-free broth
Haemolytic activity was determined as described previ-
ously [19]. Briefly, the culture supernatants were filtered
(0.22 μm membranes, Millipore MILLEX GV) to ensure
the complete cell removal and concentrated 2.5-times by
freeze-drying followed by storage at −20°C. The cell-free
culture supernatant and red blood cells (RBCs) sus-
pended in RPMI medium (1 × 108 cells/ml) were mixed
at a 1:1 (v/v) ratio, and incubated at 37°C for 15 h. After
the incubation, samples were centrifuged at 1000 g for
2 min. Absorbance of the supernatant was determined at
405 nm. Haemolysis was calculated according to the
equation: Haemolysis (%) = 100 ‐ [(Ap ‐As)/(Ap ‐An) ×
100)]; where Ap, As and An are the absorbance of the
positive control, test sample and negative control, re-
spectively. The positive control was the RBCs lysed with
SDS (0.6%) plus PBS- buffer at a 1:1 (v/v) ratio, and the
negative control was the human red blood cell suspen-
sion with RPMI plus PBS- buffer at a 1:1 (v/v) ratio. The
results are given as the ratio between the haemolysis
percentage of the test condition and control. The experi-
ments were performed three times.
A putative C. tropicalis haemolytic factor encoding gene
A putative C. tropicalis orthologue gene to HLP, which en-
codes a haemolysin-like protein gene in C. glabrata, was
searched using HLP specific primers [22] against C. tropi-
calis genomic DNA obtained as described previously [24].
The amplicon of a C. tropicalis putative HLPt (haemoly-
sin-like protein) gene was generated in 50 μl of a reaction
mixture containing 4 μl DNA (5 ng/μl), 612.5 μmol of
each dNTP (Invitrogen, Carlsbad, CA, USA), 40 pmol of
each primer, and 2.5 U of Taq polymerase (Invitrogen,
Carlsbad, CA, USA). PCR reactions were performed at
94°C for 5 min, followed by 35 cycles of 30 s at 94°C, 30 s
at 56.6°C and 1 min at 72°C, with an additional extension
(72°C, 10 min). All the PCR reactions were performed in a
GeneAmp PCR system (Eppendorf, Mastercycler gradi-
ent). The amplicon obtained was sequenced using the
DYEnamic ET dye Terminator Cycle Sequencing Kit
(Amersham Pharmacia Biotech, Inc) on MegaBACE 1000.
Characteristics of the obtained sequence such as homolo-
gies and the hydrophobicity profile were predicted by
online tools. The alignment and comparison of the nu-
cleotide and aminoacid sequences with sequences in the
databases were performed using BLAST tools available on
the NCBI (htpp://www.ncbi.nlm.nih.gov) and UniProt
(http://www.uniprot.org) websites. Transmembrane re-
gion prediction was performed using TMpred (http://
www.ch.embnet.org/software/TMPRED_form.html).
Reverse transcription–qPCR (RT-qPCR)
HLPt primers were designed for RT-qPCR analysis using
Gene Runner 3.05 software (http://www.generunner.com).
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(Table 1). Primers had melting temperatures (Tm) be-
tween 58°C and 60°C, and amplification products were
129 and 151 bp, respectively. The oligonucleotides did not
show, when analysed by themselves or together, hairpin
loops, dimmers, bulge loops or internal loops according to
program analyses. Primer specificity was checked using
BLAST analysis (Basic Local Alignment Search Tool,
http://blast.ncbi.nlm.nih.gov) searches against the Gen-
Bank database. Standard gel electrophoresis using a 2%
TBE gel was used to check for a single product of the ex-
pected size.
The assessment of differential expressions of the HLPt
gene by C. tropicalis isolates was performed following
growth in the absence of RBCs (RPMI medium) (con-
trol) and in RPMI supplemented with RBCs (test condi-
tion). After 48 h of culture, C. tropicalis cells were
harvested, washed using distilled sterile water, suspended
in Trizol® (Invitrogen, Carlsbad, CA, USA) and frozen in
liquid nitrogen. Total RNA was extracted with Trizol®,
according to the manufacturer’s instruction and sus-
pended in 30 μl of DEPC-treated water. Residual gen-
omic DNA was eliminated by DNAse I (Invitrogen,
Carlsbad, CA, USA). Purity of the extracted RNA was
determined by the 260/280 nm ratio, and integrity was
checked by electrophoresing on 1% agarose gel. RNA
was stored at −80°C until further use and quantified with
a Nanodrop ND-1000 Spectrophotometer (NanoDrop
Technologies Inc.). Reverse transcription was carried out
using 500 ng total RNA previously incubated at 64°C for
10 min and snap-cooled on ice for 2 min to denature.
First-strand cDNA was synthesized by the addition of
MgCl2 (4 mM), 2 μl of 10x PCR Buffer, dNTP mixture
(200 μM), Oligo (dT)-18 primer (0.4 μM), RNase OUT
(4 U) and reverse transcriptase RT M-ML V (0.5 U)
(Invitrogen, Carlsbad, CA, USA). The mixture was in-
cubated at 42°C for 60 min. Synthesis reactions were
performed in a GeneAmp® PCR system (Eppendorf,
Mastercycler gradient).
Real time PCR was carried out in a PTC-200 DNA En-
gine Cycler (MJ Research) with a Chromo4™ Four-Color
Real-Time System (Bio-Rad). The 20 μl reaction was
performed by using the Platinum® SYBR® Green qPCR
Supermix-UDG (Invitrogen, Carlsbad, CA, USA), 20 μM
of each primer, and 6 μl of a 1:20 cDNA dilution of eachTable 1 Primer sequences employed in the analyses of HLPt-m





*HLPt primers were designed based on the complete ORF of the putative C. tropicaisolate in their respective growing conditions. The nega-
tive controls (with no DNA template) for each primer
set were included in each run. Real-time PCR reactions
were performed at 50°C for 2 min, 95°C for 5 min,
followed by 40 cycles of 30 s at 94°C, 30 s at 56,6°C and
1 min at 72°C, with an additional extension (72°C,
10 min). Melting curve analysis was performed for each
sample to assure that a single product was produced in
each reaction.
RT-qPCR data were normalized with the constitutively
expressed β-Actin gene (ACT) [25]. Normalized data
were then used to calculate the relative gene expression
levels. An expression level corresponds to the expression
of the HLPt gene in the presence of RBCs relative to its
expression in the absence of RBCs.
Data from RT-qPCR reactions were previously ana-
lysed using MJ Opticon Monitor TM Analysis Software
(MJ Research) for determination of Cq (Quantification
cycle) for each reaction and their respective efficiencies
of amplification. The Cq value for the HLPt and ACT
genes was measured, and the expression level of HLP for
the different isolates was analysed using the efficiency
adjusted normalization method calculated by the for-
mula: Ratio = (E target)
ΔCq target(Mean control-Mean sample)/
(E ref )
ΔCq ref(Mean control-Mean sample) [26], representing the
x-fold difference from the calibrator (ACT). To deter-
mine the changes in the relative gene transcription level
presented as fold changes, a mathematical model for
relative quantification was used [27]. Three independent
experiments (biological and technical replicates) were
performed in each condition, including growth, RNA ex-
traction and qRT-PCR.Statistical analysis
SPSS 17.0 software (SPSS Inc.) was used in the statistical
analyses of haemolytic activity. A Kruskal-Wallis test
was used to evaluate the significant differences in
haemolytic activity promoted by the isolates grown in
each of the two growth conditions. The relative expres-
sion software tool REST© [26] was used to determine
the relative expression of the HLPt gene in the different
culture conditions evaluated and to test whether the ex-
pression differences were significant. Gene expression in
the test condition was considered significantly different,RNA expression and respective amplicon sizes
Amplicon size Reference
GG 151 pb This study
AG
GC 129 pb Vandeputte et al. [25]
GC
lis haemolysin-like protein gene sequence using Gene Runner 3.05 software.
Table 2 Effect of human red blood cells (RBCs) on
















1Relative haemolysis given by the ratio of haemolysis measured from cell-free
culture supernatant obtained following growth in the presence of RBCs relative
to haemolysis measured from culture supernatant obtained following growth in
the absence of RBCs; *positive effect significant at p < 0.05 by the Kruskal-
Wallis Test.
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p < 0.001.
Results
Effect of red blood cells on production of haemolytic
factor
Differences in the levels of haemolysis obtained from
cell-free broth following growth in the absence and pres-
ence of human RBCs are illustrated in Figure 1. All iso-
lates tested produced a haemolytic factor that promoted
the release of haemoglobin from human RBCs. The rela-
tive haemolysis data, giving by the ratio of the haemoly-
sis percentage obtained in cultures in the presence of
human RBCs relative to that in the absence of RBCs
(RPMI cultures), are shown in Table 2. For 60% of the
isolates, human RBCs had a positive effect on haemolysis
promotion (p < 0.05) (Table 2). Among these isolates, for
isolate 189.06 (lowest relative haemolysis), the percent-
ages of haemolysis from cell-free culture supernatants
obtained following growth in the presence of RBCs rela-
tive to haemolysis in the absence of RBCs were 2.73 ±
0.1/2.57 ± 0.06; for isolate 254.07 (highest relative haem-
olysis), the percentages of haemolysis from cell-free cul-
ture supernatants obtained following growth in the
presence of RBCs relative to haemolysis in the absence
of RBCs were 3.83 ± 0.31/1.71 ± 0.34.
For 40% of the isolates, no significant differences were
observed in the haemolytic activity between cultures
grown in the presence or absence of RBCs (Table 2).
Among these isolates, for isolate 197.06 (lowest relative
haemolysis), the percentages of haemolysis from cell-
free culture supernatants obtained following growth in
the presence of RBCs relative to haemolysis in the ab-
sence of RBCs were 1.63 ± 0.2/1.74 ± 0.08; for isolateFigure 1 Representative photograph showing haemolysis
promoted by the haemolytic factor produced by C. tropicalis.
For haemolysis assays, cell-free culture supernatants and RBCs were
mixed at a 1:1 (v/v) ratio following incubation at 37°C for 15 h. (+)
positive control (total lyses of RBCs in the presence of SDS), (1–2)
haemolysis promoted by isolate 344.07 following growth in the presence
and absence of RBCs, respectively, and (−) negative control (RBCs
cells suspension with RPMI plus PBS buffer).335.07 (highest relative haemolysis), the percentages of
haemolysis from cell-free culture supernatants obtained
following growth in the presence of RBCs relative to
haemolysis in the absence of RBCs were 2.11 ± 0.28/
2.21 ± 0.06. Additionally, to verify that RPMI medium
did not promote human RBC haemolysis, a 2.5-times
concentrated RPMI medium was tested by a haemolysis
assay. No RBC lysis was observed (data not shown).
A putative C. tropicalis haemolysin-like protein gene (HLPt)
The employment of C. glabrata HLP gene primers
against C. tropicalis genomic DNA resulted in an
amplicon of approximately 400 bp (data not shown).
The BLASTN analysis (BLASTN algorithm against the
GenBank database) revealed that the sequence of the
amplicon exhibited high identity (98%) to a C. tropicalis
predicted protein mRNA (Candida tropicalis MYA-3404,
GenBank: XM_002547122). The corresponding amino
acid sequence of the obtained ORF had significant similar-
ities to an uncharacterized threonine-rich GPI-anchored
glycoprotein of the fission yeast Schizosaccharomyces
pombe (EMBL Uniprot database: Q96WV6), indicating
the presence of a possible domain that leads to a cell sur-
face subcellular location. Furthermore, the in silico ana-
lysis inferred gene ontology of the HLPt gene product as a
cellular component located on the external side of the cell
wall. Moreover, the BLASTN analysis also revealed a high
identity (70%) to a C. albicans hypothetical protein
SC5314 (CaO19.11047, GenBank: XM_709892), anno-
tated as an ORF similar to the DAN4p cell wall manno-
protein of Saccharomyces cerevisiae (EMBL Uniprot
database: P47179). Hydropathy plots show comparable
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predicted protein of C. tropicalis and the C. albicans
hypothetical protein (Figure 2), supporting the hypothesis
that the C. tropicalis predicted protein may be correlated
to a cell wall mannoprotein, though the achieved data do
not allow its classification.A
B
Figure 2 Hydrophobicity profile obtained by TMpred analyses. (A) TM
MYA-3404, GenBank: XM_002547122). (B) TMpred obtained for C. albicans h
Saccharomyces cerevisiae cell wall mannoprotein (see Results section).The complete ORF of the C. tropicalis sequence was
used to design gene-specific primers for a C. tropicalis pu-
tative haemolysin-like protein (HLPt) gene. The employ-
ment of these primers was successfully applied against C.
tropicalis genomic DNA which resulted in an amplicon of
151 bp (data not shown) (Table 1).pred obtained for C. tropicalis predicted protein (Candida tropicalis
ypothetical protein (CaO19.11047, GenBank: XM_709892) similar to a
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Basic Local Alignment Search Tool (BLAST) analysis indi-
cated that each primer pair employed in qPCR assays was
specific for C. tropicalis HLPt and ACT genes and would
not cross-react with sequences from other organisms (data
not shown). Gel electrophoresis and melting curve ana-
lyses confirmed the presence of the expected qPCR prod-
ucts, and the absence of unwanted non-specific products,
confirming that each primer pair was specific for its corre-
sponding C. tropicalis gene. Non-inoculated media failed
to show evidence of gene expression (data not shown).
We found that the HLPt and ACT genes were expressed
either in the presence or absence of RBCs at 48 h.
Table 3 shows the relative expression of the HLPt gene
in C. tropicalis. The mRNA levels of the HLPt gene were
higher in culture medium supplemented with human
RBCs than in RPMI medium alone for 60% of C. tropica-
lis isolates at statistically significant (p < 0.001) levels,
with an induction factor ranging from 1.044 to 6.965-
fold. All isolates in which the HLPt gene was up-
regulated in the presence of human RBCs also exhibited
higher haemolytic activity following growth in the pres-
ence of RBCs compared to that observed in the absence
of RBCs (Table 2).
On the other hand, transcript levels were low for 40%
of the isolates at statistically significant (p < 0.001) levels
with a repression factor of 1.338 to 4.429-fold. These
isolates exhibited the same extent of haemolytic activity
in either the presence or absence of RBCs in culture
medium.
Discussion
Despite the clinical importance of C. tropicalis, studies
examining virulence attributes expressed by this speciesTable 3 Relative expression of the HLPt gene by Candida
tropicalis clinical isolates following growth in either the
absence (RPMI medium) or the presence of human red
blood cells (RBCs) (RPMI + RBCs)
Relative expression
Isolates Fold changes in mRNA expression












*Significantly different by REST Software (p < 0.001).are scarce. In particular, studies regarding the produc-
tion of molecules exhibiting haemolytic activity by Can-
dida species are limited.
The ability of pathogenic microorganisms to acquire
elemental iron has been shown to be essential to their
survival within the mammalian host [28]. C. albicans
may acquire iron from human RBCs by producing a
haemolytic factor that consist of a cell wall mannopro-
tein with its sugar fraction identified as a cell-wall man-
nan; the mannan binds to RBC band 3 protein, causing
RBC rupture and consequent release of haemoglobin, a
source of iron for the yeast [13,14].
Luo et al. [16] were the first to describe that C. tropi-
calis exhibits a haemolytic activity when grown on blood
agar. We have first demonstrated that haemolytic factor
is released in the culture supernatant of C. tropicalis iso-
lates [19], and that it is produced by different isolates in-
dependent of their clinical origin [19,29]. Further, we
demonstrated different abilities of haemolytic factor pro-
duction among Candida species associated with blood-
stream infections, where C. tropicalis exhibited higher
haemolysis than C. albicans [20].
Concerning the cultures conditions under which C.
tropicalis exhibits a haemolytic capability, it has been
demonstrated that the production of haemolytic factor
by this species occurs in a glucose-dependent manner
[19,30], and that it is not influenced by an increased at-
mosphere of carbon dioxide [19], differing from that ob-
served in the prokaryote model.
Here, we evaluated for the first time the influence of
human RBCs on the production of haemolytic factor by
clinical isolates of C. tropicalis. In agreement with previ-
ous results [19,20], the production of haemolytic mole-
cules, following growth in RPMI medium, was a common
trait of C. tropicalis isolates, e.g., all tested isolates pro-
duced haemolytic factor under this culture condition;
however, growth in the presence of human RBCs resulted
in higher haemolytic factor production for 6 out of 10 iso-
lates tested compared to that obtained in medium where
RBCs were absent. Our data revealed that human red
blood cells seem to modulate the production of haemo-
lytic factor and that it occurs in an isolate-dependent fash-
ion. Although the haemolytic molecule produced by C.
tropicalis has not yet been characterised at a biochemical
level, we have recently suggested that it may be a manno-
protein, based on its affinity to Concanavalin A, similarly
to that described for C. albicans [20]. Recently, it has been
shown that C. albicans increases cell wall mannoproteins
in response to blood [31]. According to these authors, the
cell wall structure and composition, e.g., mannan chain
length and complexity, are altered when C. albicans cells
are grown in the presence of blood rather than standard
laboratory growth media [31]. Moreover, it has been pro-
posed that C. albicans upregulates cell wall mannan and/
Furlaneto et al. Journal of Biomedical Science  (2015) 22:13 Page 7 of 8or mannoprotein as a defense mechanism [32]. Our data
raise the hypothesis that in C. tropicalis, the cell wall com-
position and/or architecture may be altered in response to
the presence of red blood cells, in a similar fashion to that
observed for C. albicans. Currently, the influence of
growth conditions on the Candida spp cell wall remains
largely unexplored, although the cell wall is a key effector
of cell morphology and an active modulator of host im-
mune defences.
In this study, we aimed to identify a putative gene en-
coding a haemolysin-like protein in C. tropicalis that
was named HLPt in analogy to its C. glabrata ortholo-
gue (HLP) [22]. To evaluate the transcription levels of
HLPt we employed the quantitative real-time RT-PCR
method. Our results revealed the presence of HLPt tran-
scripts in all C. tropicalis isolates under both culture
conditions tested, e.g., RPMI medium alone and RPMI
supplemented with human red blood cells, suggesting
that in C. tropicalis the HLPt gene may have an ubiqui-
tous expression and that the HLPt gene product is a
common characteristic in this species. To verify whether
human RBCs modulate HLPt gene expression in C. tro-
picalis and to evaluate a possible correlation between
the transcript levels and the profile of haemolysis pro-
moted by different clinical isolates, the fold expression
(expression level) of the HLPt gene was compared be-
tween the two culture conditions, e.g., absence and pres-
ence of RBCs. For the majority of isolates, the presence
of RBCs upregulated HLPt transcription. For these iso-
lates, we observed a positive correlation between HLPt
induction and the production of haemolytic factor, re-
vealed by the levels of haemolysis. On the other hand,
some isolates showed RBC-repressed control of HLPt,
although the observed haemolysis remained constant
(Table 3). The reason for this absence of correlation be-
tween reduced expression of HLPt-mRNA and a reduc-
tion in haemolysis is unknown. One possible explanation
may be related to cell density effects that may differed
among isolates. Another possibility is that differences
among isolates in the ability to promote the yeast-to-hypha
transition may affect haemolysis levels. In another set of
experiments carried out in our laboratory, we observed
that C. tropicalis cells undertake a yeast-to-filamentous
growth transition (hypha + pseudohypha) when cultured in
the presence of RBCs and that this frequency is variable
among isolates (unpublished data). According to Manns
et al. [14], C. albicans hyphal cells were associated with
higher haemolysis levels than blastoconidial cells.
As far as we know, this is the first study to analyse the
differential expression of a putative haemolytic factor en-
coding gene in pathogenic Candida species. Future work
must focus on the construction of C. tropicalis HLPt
null mutants to evaluate environmental conditions that
have effects on haemolysis.Conclusions
We demonstrated that human red blood cells influence
the production of haemolytic factor by clinical isolates
of C. tropicalis. In addition, this study provides evidence
that RBCs induce changes in the transcription levels of
the putative C. tropicalis HLPt gene in an isolate-
dependent manner.
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